ABSTRACT
Background: Adipolin, the novel adipokine that is proposed to be reduced in diabetes, obesity and inflammation, may improve glycemic control. It is known that coenzyme Q10 could improve insulin sensitivity. The aim of the current study was to investigate the effect of Q10 supplementation on adipolin concentration and glucose metabolism in overweight and obese diabetic patients. Material & Methods: Sixty four patients with type 2 diabetes and 25Subject(s)
Adipokines/blood
, Diabetes Mellitus, Type 2
, Obesity
, Ubiquinone/analogs & derivatives
, Adult
, Diabetes Mellitus, Type 2/blood
, Diabetes Mellitus, Type 2/drug therapy
, Female
, Glycated Hemoglobin/metabolism
, Humans
, Male
, Middle Aged
, Obesity/blood
, Obesity/diet therapy
, Ubiquinone/administration & dosage
